Delivery Order SPE2DB20D2014-SPE2DB24FA93Y
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,509.60 firm fixed-price delivery order is for the supply of 4,563,731,412 units of Rosuvastatin Calcium 20 mg tablets. The contract has a period of performance through February 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $19,800.24 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for 4,563,597,742 tablets of Rosuvastatin Calcium 10 mg. The delivery order has a period of performance through February 9, 2024. Amerisourcebergen Drug Corp, as the prime contractor, provides a wide range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,268.53 firm fixed-price delivery order is for the supply of 500 units of Rosuvastatin Calcium 5 mg tablets. The contract has an ultimate completion date of December 19, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation is for the delivery of 500 units of Rosuvastatin Calcium 5 mg tablets. The award has a ceiling value of $23,241.90 and a completion date of February 26, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that has an Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, to provide 1,000 units of the prescription drug Rosuvastatin Calcium 20 mg tablets. The $5,440.08 award has a completion date of January 30, 2024 and is not designated as a set-aside contract. Amerisourcebergen Drug Corp currently holds an indefinite delivery contract with a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,993.20 firm fixed-price delivery order is for the supply of Rosuvastatin Calcium 40 mg tablets, a cardiovascular medication, with a performance period through March 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract (SPE2DB22D3011|SPE2DB24FQ0FC) to AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. The $35,103.25 contract is for the supply of 500 units of Rosuvastatin Calcium 5 mg tablets. This delivery order falls under AmerisourceBergen's existing indefinite delivery contract with DLA, valued at up to $999,999,999.00 through December 2025. AmerisourceBergen, a for-profit organization, serves...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 20mg Rosuvastatin Calcium tablets (1,000 per bottle) to the Defense Logistics Agency (DLA). The $1,170.92 firm-fixed-price delivery order was awarded on June 25, 2024, with a completion date of June 26, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is for the delivery of 4,560,678,255 units of Rosuvastatin Calcium 10 mg tablets. The $1,305.52 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, under contract number SPE2DX15D1205|SPE2DX23F56W7. The contract has an ultimate completion date of April 24, 2023. Amerisourcebergen holds a significant Indefinite Delivery...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Rosuvastatin Calcium 10 mg tablets. The contract has a potential value of $1,533.60 and a completion date of December 28, 2023. No set-aside designation was used. AmerisourceBergen Drug Corp, as the prime contractor, will provide the pharmaceutical product to support DLA Troop Support Medical...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FA93YDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is for the delivery of 4,563,482,111 units of Rosuvastatin Calcium 20 mg tablets in 500-count bottles, with a firm fixed price of $6,400.32 and a completion date of January 31, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is the prime contractor on this delivery order contract, which is part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 and running through December 31, 2025. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's military treatment programs and medical facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 1/30/24 |